Literature DB >> 10444362

Cadaveric skin allograft-associated cytomegalovirus transmission in a mouse model of thermal injury.

H Kobayashi1, M Kobayashi, R L McCauley, D N Herndon, R B Pollard, F Suzuki.   

Abstract

As a routine procedure to provide temporary coverage for burn wounds, cadaveric skin allografts have been used in patients with massive thermal injuries. In this study, CMV infection associated with skin grafting was investigated. Graft-associated CMV transmission was shown in a mouse model of thermal injury. Skins from mice 100 days after a nonlethal dose of murine CMV (MCMV) infection contained MCMV DNA and mRNA, although the virus was not isolated from these murine skins. When these skins were grafted to burned mice, the marked growth of MCMV was demonstrated in salivary glands. No viral growth was shown in the salivary glands of unburned mice or CMV sero(+) mice after grafting with these skins. When severe combined immunodeficient beige (SCID-beige) mice were used as recipients for CMV sero(+) skins, all mice died within 30 days after the grafting. Only 1 PFU/mouse of MCMV was shown to be 1 LD(50) in SCID-beige mice, while a 50% mortality rate was shown in normal unburned mice infected with 5 x 10(5) PFU/mouse of MCMV. This indicates that a very small amount of CMV contained in skins is sufficient to induce CMV infection in immunocompromised hosts. On the other hand, human CMV (HCMV) DNA and mRNA were detected by PCR analysis in 55% (DNA) and 33% (mRNA) of cadaveric skins, although the isolation of HCMV from cadaveric skin homogenates was not achieved in tissue cultures. CMV sero(-) patients with severe burn injuries may have a high risk for CMV infection associated with allografts of cadaveric skins. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10444362     DOI: 10.1006/clim.1999.4735

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

Review 1.  Resistant pathogens, fungi, and viruses.

Authors:  Christopher A Guidry; Sara A Mansfield; Robert G Sawyer; Charles H Cook
Journal:  Surg Clin North Am       Date:  2014-10-03       Impact factor: 2.741

Review 2.  Update on the current status of cytomegalovirus vaccines.

Authors:  Heungsup Sung; Mark R Schleiss
Journal:  Expert Rev Vaccines       Date:  2010-11       Impact factor: 5.217

3.  Case report: cytomegalovirus primoinfection may be associated with severe outcome in burns.

Authors:  C Augris; M Benyamina; F Rozenberg; S Gaucher; D Wassermann; C Vinsonneau
Journal:  Ann Burns Fire Disasters       Date:  2007-12-31

4.  Human cytomegalovirus infection of a severe-burn patient: evidence for productive self-limited viral replication in blood and lung.

Authors:  Klaus Hamprecht; Mathias Pfau; Hans-Eberhard Schaller; Gerhard Jahn; Jaap M Middeldorp; Hans-Oliver Rennekampff
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

5.  Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.

Authors:  Luka Cicin-Sain; Ivan Bubić; Margit Schnee; Zsolt Ruzsics; Christian Mohr; Stipan Jonjić; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

6.  Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns.

Authors:  Josef Haik; Gil Nardini; Noga Goldman; Gilli Galore-Haskel; Moti Harats; Isaac Zilinsky; Oren Weissman; Jacob Schachter; Eyal Winkler; Gal Markel
Journal:  Oncotarget       Date:  2016-01-19

7.  Observation of viable alloskin vs xenoskin grafted onto subcutaneous tissue wounds after tangential excision in massive burns.

Authors:  Haibin Zuo; Guodong Song; Wen Shi; Jun Jia; Yonghu Zhang
Journal:  Burns Trauma       Date:  2016-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.